Baxalta: A Rare Undervalued Biopharmaceutical Company
July 23, 2015 at 08:43 AM EDT
Baxalta may be new, but it is no start-up company. Baxalta has estimated annual revenues of around $6 billion, and 16,000 employees.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.